Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30 | 40 | N/A | 200 | 10 |
| Receivables | 10 | 10 | N/A | 80 | 190 |
| Other current assets | 10 | 10 | 0 | 10 | 740 |
| TOTAL | $50 | $60 | $N/A | $290 | $940 |
| Non-Current Assets | |||||
| Investments And Advances | 70 | 70 | 0 | 0 | 8,730 |
| Other Non-Current Assets | 5 | 5 | 0 | 75 | 115 |
| TOTAL | $75 | $75 | $N/A | $75 | $8,845 |
| Total Assets | $240 | $250 | $N/A | $490 | $9,930 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | N/A | 700 | 0 |
| Accounts payable and accrued liabilities | 90 | 180 | 0 | 70 | 200 |
| Accrued Expenses | 30 | 0 | N/A | 10 | 0 |
| TOTAL | $820 | $880 | $N/A | $790 | $200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,840 | 5,840 | N/A | 5,840 | 5,840 |
| Other Non-Current Liabilities | 8,510 | 8,690 | 0 | 7,960 | 8,920 |
| TOTAL | $14,350 | $14,530 | $N/A | $13,800 | $14,760 |
| Total Liabilities | $15,180 | $15,420 | $N/A | $14,600 | $14,640 |
| Shareholders' Equity | |||||
| Common Shares | 1,050 | 1,040 | N/A | 1,010 | 990 |
| Retained earnings | -41,700 | -41,520 | N/A | -40,600 | -42,840 |
| Other shareholders' equity | 350 | 10 | 0 | 360 | 340 |
| TOTAL | $-14,940 | $-15,160 | $N/A | $-14,100 | $-4,700 |
| Total Liabilities And Equity | $240 | $260 | $0 | $500 | $9,940 |